학술논문
Daunorubicin-cytarabine liposome (CPX-351) in the management of newly diagnosed secondary AML: A new twist on an old cocktail
Document Type
Review Article
Author
Source
In Best Practice & Research Clinical Haematology June 2019 32(2):127-133
Subject
Language
ISSN
1521-6926